CC BY 4.0 · Int Arch Otorhinolaryngol 2024; 28(02): e234-e239
DOI: 10.1055/s-0043-1772494
Original Research

Olfaction and Quality of Life in Patients with Eosinophilic CRS Undergoing Endoscopic Sinus Surgery

1   Department of Otolaryngology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil
2   Department of Otolaryngology, Policlinica de Botafogo, Rio de Janeiro, RJ, Brazil
3   Department of Otorhinolaryngology and Head and Neck Surgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Richard Louis Voegels
4   Department of Otolaryngology, University of São Paulo, São Paulo, SP, Brazil
,
Rogério Pezato
5   Department of Otolaryngology and Head & Neck Surgery, ENT Research Laboratory, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Andrew Thamboo
6   Division of Rhinology, University of British Columbia, Vancouver, Canada
,
Eduardo Macoto Kosug
3   Department of Otorhinolaryngology and Head and Neck Surgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil
,
Ana Clara Miotello Ferrão
7   Department of ENT, Policlinica de Botafogo, Rio de Janeiro, RJ, Brazil
,
Raíssa de Figueiredo Neves
7   Department of ENT, Policlinica de Botafogo, Rio de Janeiro, RJ, Brazil
,
Valéria Maria Barcia Castilla
7   Department of ENT, Policlinica de Botafogo, Rio de Janeiro, RJ, Brazil
,
Luis Carlos Gregório
3   Department of Otorhinolaryngology and Head and Neck Surgery, Universidade Federal de São Paulo, São Paulo, SP, Brazil
› Author Affiliations
Funding The author(s) received no financial support for the research.

Abstract

Introduction Chronic rhinosinusitis (CRS) is a common inflammatory disease. This high prevalence leads to high direct and indirect public health costs, which include medical visits, laboratory tests and imaging, pharmacotherapy, hospitalizations, and surgical treatment. Furthermore, CRS has a substantial impact on patient quality of life, affecting productivity and being a common cause of absence from work CRS-associated olfactory dysfunction is highly prevalent, the actual effectiveness of surgical intervention remains inconsistent. Although there are studies evaluating the postoperative course of patients with eosinophilic Chronic rhinosinusitis (eCRS) treated with high-volume budesonide irrigation, there is little objective information regarding the impact of this intervention on olfactory status and quality of life.

Objective To conduct a pre- and postoperative analysis of olfaction and quality of life in patients with eCRS treated with surgical intervention followed by high-volume budesonide nasal irrigation.

Methods Prospective, descriptive, uncontrolled study of patients with eCRS. All patients underwent pre- and postoperative nasal endoscopy, SNOT-22 questionnaire, and the University of Pennsylvania Smell Identification Text (UPSIT), always by the same previously trained examiner. The SNOT-22 questionnaire and the UPSIT were readministered to all patients at 3 months, 6 months, and 1 year postoperatively, and scores compared with those obtained preoperatively.

Results Twenty patients were included in the study, 13 males and 7 females, between the ages of 23 and 65; 8 patients had comorbid asthma. Quantitative evaluation using the UPSIT test showed a significant improvement in olfaction 3 months after surgery, which remained 6 months and 1 year after surgery (p = 0.0063).

There was no significant association between eosinophil concentrations in polypoid tissue and postoperative SNOT-22 and UPSIT results. Patients with tissue eosinophils >50 had a lower preoperative UPSIT score. As early as 3 months postoperatively, a significant improvement in quality of life was already noticeable, as represented by a decrease in SNOT-22 values, which persisted through the 1-year postoperative follow-up evaluation (p = 0.0005). Quantitative evaluation using the UPSIT test showed a significant improvement in olfaction 3 months after surgery, which remained 6 months and 1 year after surgery (p = 0.0063).

Conclusion Surgery effectively controlled eCRS in patients who adhered to high-volume budesonide nasal irrigation postoperatively. There were significant improvements in quality of life and olfaction, which persisted at least up to one year postoperatively.



Publication History

Received: 10 February 2023

Accepted: 18 June 2023

Article published online:
16 February 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Fokkens WJ, Lund VJ, Hopkins C. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 2020; 58 (Suppl S29) 1-464
  • 2 Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10 2014; (260) 1-161
  • 3 Hastan D, Fokkens WJ, Bachert C. et al. Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study: Chronic rhinosinusitis in Europe. Allergy 2011; 66 (09) 1216-1223
  • 4 Pilan RR, Pinna FR, Bezerra TF. et al. Prevalence of chronic rhinosinusitis in Sao Paulo. Rhinology 2012; 50 (02) 129-138
  • 5 Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol Head Neck Surg 2011; 144 (03) 440-445
  • 6 Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Allergy Rhinol (Providence) 2010; 1 (01) 8
  • 7 Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2004; 193 (05) 3-5
  • 8 Reddel HK, Bacharier LB, Bateman ED. et al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur Respir J 2021; 59 (01) 2102730
  • 9 Rudmik L, Hoy M, Schlosser RJ. et al. Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations. Int Forum Allergy Rhinol 2013; 3 (04) 281-298
  • 10 Welch KC, Thaler ER, Doghramji LL, Palmer JN, Chiu AG. The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy 2010; 24 (01) 26-28
  • 11 Snidvongs K, Pratt E, Chin D, Sacks R, Earls P, Harvey RJ. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol 2012; 2 (05) 415-421
  • 12 Mullol J, Obando A, Pujols L, Alobid I. Corticosteroid treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin North Am 2009; 29 (04) 657-668
  • 13 Briner HR, Jones N, Simmen D. Olfaction after endoscopic sinus surgery: long-term results. Rhinology 2012; 50 (02) 178-184
  • 14 Kohli P, Naik AN, Farhood Z. et al. Olfactory Outcomes after Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A Meta-analysis. Otolaryngol Head Neck Surg 2016; 155 (06) 936-948
  • 15 Snidvongs K, Chaowanapanja P, Aeumjaturapat S, Chusakul S, Praweswararat P. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis?. Am J Rhinol 2008; 22 (05) 483-486
  • 16 Steinke JW, Payne SC, Tessier ME, Borish LO, Han JK, Borish LC. Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis. J Allergy Clin Immunol 2009; 124 (06) 1352-4.e7
  • 17 Lino WVS, Bachi ALL, Neto JAM, Caetani G, Amaral JBD, Pezato R. CD133, a Progenitor Cell Marker, is Reduced in Nasal Polyposis and Showed Significant Correlations with TGF-β1 and IL-8. Int Arch Otorhinolaryngol 2021; 26 (01) e091-e096
  • 18 Imunologia 2010 (dayane/jhenifer/rose/silvia). Imunologia: Citocinas [Internet]. Imunologia. 2010 [cited 2022 Sep 12]. Available from: http://imunofarma.blogspot.com/2010/09/citocinas.html
  • 19 Montassier H, Calado AMC. Citocinas/Interleucina S. :85.
  • 20 Kosugi EM, Chen VG, Fonseca VM, Cursino MMP, Mendes Neto JA, Gregório LC. Translation, cross-cultural adaptation and validation of SinoNasal Outcome Test (SNOT): 22 to Brazilian Portuguese. Rev Bras Otorrinolaringol (Engl Ed) 2011; 77 (05) 663-669
  • 21 Fornazieri MA, Pinna Fde R, Bezerra TFP, Antunes MB, Voegels RL. Aplicabilidade do teste de identificação de olfato da Universidade da Pensilvânia (SIT) para brasileiros: estudo piloto. Rev Bras Otorrinolaringol (Engl Ed) 2010; 76 (06) 695-699
  • 22 Tao X, Chen F, Sun Y. et al. Prediction models for postoperative uncontrolled chronic rhinosinusitis in daily practice. Laryngoscope 2018; 128 (12) 2673-2680
  • 23 Guo CL, Wang CS, Liu Z. Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 2022; 22 (01) 16-23
  • 24 Zhang L, Zhang Y, Gao Y. et al. Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma. Rhinology 2020; 58 (02) 126-135